What is epidermoid lung cancer?

ahsan65@gmail.comJune 6, 2025

0 0 2 minutes read

Treatment options for epidermoid lung cancer will depend on various factors, such as the stage of the disease, the type, that certain genetic mutations feed cancer and your overall health.

Surgery

If cancer has not spread outside the lung, surgery can be an option. There are three main types of lung cancer surgery:

Corner resection A surgeon only withdraws a small part of the lung.
Lush A lung lobe is removed.
Pneumonectomy A whole lung is deleted.

Chemotherapy

Chemotherapy uses drugs to kill cancer cells in the body and is normally injected into a vein.

With regard to epidermoid lung cancer, chemo can be given before or after surgery, or to slow down cancer growth and improve symptoms if lung cancer has spread. Epidermoid lung cancer does not react as well to chemotherapy and radiotherapy as other types of tumors.

Chemotherapy drugs commonly used for epidermoid carcinoma are:

cisplatin, often combined with gemcitabine
carboplatin
Paclitaxel at albumin

Chemotherapy can have many side effects, including:

Anemia
Diarrhea or constipation
Fatigue
Loss
Increased risk of infections
Nausea and vomiting

Radiotherapy

Radiotherapy uses energy beams to destroy cancer cells from the body. The radiation of the external beam, which is aimed at lung cancer from the outside of the body, is the type most often used to treat squamous lung cancer.

Certain possible side effects of radiation are:

Fatigue
Nausea and vomiting
Radiological pneumonitis, due to changes in pulmonary tissue
Lung healing
Shortness of breath
Problem swallowed

Targeted treatments

Targeted treatments are focused on certain gene changes in cancer cells. If a person’s tumor contains specific anomalies, these therapies can be effective. These genetic mutations tend to occur less frequently in epidermoid lung cancers than in other types of lung cancer.

Your doctor can test your tumor for specific genetic defects that can respond to targeted therapies.

Immunotherapy

Immunotherapy consists in forming your body’s immune system to detect and destroy cancer cells. There are four immunotherapies approved by the FDA for people with CBNPC, including epidermoid lung cancer.

These drugs are called inhibitors of control points and encourage the immune system to embark on overdrive.

Research has revealed that the combination of the Pembrolizumab immunotherapy medication (Keytruda) suffering from chemotherapy has considerably prolonged survival in people with advanced epidermoid lung cancer.

Angiogenesis inhibitors

Angiogenesis is the body process that makes new blood vessels. Angiogenesis inhibitors prevent the formation of these new vessels, which prevents the tumor from having access to blood. Without oxygen and nutrients found in the blood, the tumor should die or stop growing.

Ramumirumab (Cyramza) is an angiogenesis inhibitor which is approved to be used with Docktaxel, a chemotherapy medication, when cancer has metastasé.

ahsan65@gmail.comJune 6, 2025

0 0 2 minutes read